TAMBORINO, Carmine
 Distribuzione geografica
Continente #
NA - Nord America 3.209
EU - Europa 2.075
AS - Asia 1.497
SA - Sud America 204
AF - Africa 34
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 7.033
Nazione #
US - Stati Uniti d'America 3.153
IT - Italia 1.287
SG - Singapore 633
CN - Cina 460
BR - Brasile 173
DE - Germania 153
GB - Regno Unito 130
HK - Hong Kong 128
UA - Ucraina 127
TR - Turchia 102
FI - Finlandia 79
VN - Vietnam 59
FR - Francia 55
SE - Svezia 47
NL - Olanda 43
PL - Polonia 39
RU - Federazione Russa 34
AT - Austria 31
CA - Canada 25
MX - Messico 24
ZA - Sudafrica 21
BD - Bangladesh 20
ID - Indonesia 20
IN - India 20
JP - Giappone 19
AR - Argentina 14
BE - Belgio 11
CZ - Repubblica Ceca 11
ES - Italia 9
IQ - Iraq 9
AU - Australia 7
CO - Colombia 6
KE - Kenya 6
HN - Honduras 4
UZ - Uzbekistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
DZ - Algeria 3
EU - Europa 3
IR - Iran 3
KR - Corea 3
SA - Arabia Saudita 3
UY - Uruguay 3
AO - Angola 2
CH - Svizzera 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
LT - Lituania 2
NP - Nepal 2
PK - Pakistan 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
SY - Repubblica araba siriana 2
VE - Venezuela 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
EC - Ecuador 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GF - Guiana Francese 1
GR - Grecia 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TW - Taiwan 1
Totale 7.033
Città #
Ashburn 415
Singapore 363
Woodbridge 337
Fairfield 272
Houston 206
Chandler 193
Rome 174
Beijing 158
Santa Clara 142
Ann Arbor 136
Jacksonville 135
Hong Kong 128
Wilmington 91
Seattle 89
Milan 88
Ferrara 87
Cambridge 82
Florence 79
New York 73
Los Angeles 62
Dallas 51
Nanjing 50
Izmir 46
Munich 43
Princeton 41
The Dalles 39
Boardman 38
Warsaw 37
Shanghai 34
Dearborn 29
Helsinki 27
Vienna 26
Bremen 22
London 22
San Diego 21
Addison 19
Ho Chi Minh City 19
Buffalo 18
Turku 18
Nanchang 17
São Paulo 17
Mexico City 16
Tokyo 16
Cagliari 13
Chennai 13
Jiaxing 13
Shenyang 13
Bologna 12
Jakarta 12
Tianjin 12
Brooklyn 11
Brussels 11
Hanoi 11
Hebei 11
Johannesburg 11
Norwalk 11
Padova 11
Phoenix 11
Brno 10
Chicago 10
Montecatini Terme 10
Naples 10
Reggio Emilia 10
Atlanta 9
Boston 9
Montreal 9
Poplar 9
Stockholm 9
Taranto 9
Turin 9
Verona 9
Bari 8
Changsha 8
Hefei 8
Orem 8
Redwood City 8
Terni 8
Belo Horizonte 7
Falkenstein 7
Frankfurt am Main 7
Jinan 7
Manchester 7
Prato 7
San Francisco 7
Venice 7
Baghdad 6
Cape Town 6
Denver 6
Moscow 6
Mountain View 6
San Mateo 6
Zhengzhou 6
Auburn Hills 5
Brescia 5
Columbus 5
Curitiba 5
Guangzhou 5
Lucca 5
Marino 5
Perugia 5
Totale 4.460
Nome #
Affidabilità delle mappe TC perfusionali nel definire il core infartuale e la penombra ischemica in pazienti con ictus ischemico acuto 1.366
Biological markers in cerebrospinal fluid for axonal impairment in multiple sclerosis: acetylcholinesterase activity cannot be considered a useful biomarker 216
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 212
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 212
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 204
Chlamydia pneumoniaespecific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms 203
Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis 202
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 196
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 195
Adding blood to agitated saline significantly improves detection of right-to-left shunt by contrast-transcranial color-coded duplex sonography 187
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 187
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 178
Leptin/adiponectin ratio predicts post-stroke neurological outcome 169
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 166
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 163
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 160
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 151
DNA Sequences of Parachlamydia-like organisms in CSF of Patients with Neurological Disorders 151
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 150
Relapsing-remitting neurological bladder as onset of immune-mediated vasculitis of spinal cord (MPO-ANCA) 148
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 147
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR THE IMPLEMENTATION A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES IN MS. 146
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 145
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 139
Timing of Serum Soluble HLA-G Levels in Acute and Subacute Phases After Spontaneous Intracerebral Hemorrhage 136
Detection of Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response in a subset of patients with progressive forms of multiple sclerosis 126
Effect of HLA-G gene polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 124
CSF levels and soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis 124
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS - ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES. 124
EBV-specific intrathecal oligoclonal antibody response in multiple sclerosis patients 111
Possibile association between cerebrospinal fluid and serum levels of active matrix metalloproteinase-2 and MRI inactivity in multiple sclerosis patients 100
null 97
MMP-9 isoforms in serum of Multiple Sclerosis patients 95
Effects of anticoagulants on the activity of gelatinases 91
null 90
null 88
Effects of anticoagulants on the activity of gelatinases 79
null 66
null 66
Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 63
Identification of circulating nonclassic human leukocyte antigen G (HLA-G)-dimer molecules in cerebrospinal fluids from MS stable patients. 58
null 45
null 40
Totale 7.116
Categoria #
all - tutte 28.820
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.820


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021310 0 0 0 0 0 37 20 55 24 77 65 32
2021/2022429 15 51 28 30 7 20 14 26 14 37 34 153
2022/2023803 43 66 26 84 113 79 63 66 106 29 60 68
2023/2024763 36 34 35 38 102 204 28 68 33 34 53 98
2024/20251.306 49 54 112 98 191 128 42 35 206 105 177 109
2025/20261.581 314 92 196 358 404 217 0 0 0 0 0 0
Totale 7.116